- Home
- / Treace Medical Concepts
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Treace Medical Concepts financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.8
2024-10-29
Market Capitalization
$299.8 M
2024-10-29
Revenue
$212.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 94.4M | 141.8M | 187.1M | 209.4M | 212.7M |
| Cost of goods sold | 17.8M | 27.5M | 35.2M | 41.1M | 42.9M |
| Gross profit | 76.6M | 114.3M | 151.9M | 168.3M | 169.8M |
| Gross profit margin, % | 80.6% | 81.2% | 80.4% | 79.8% | |
| General and administrative expense | 18.4M | 33.0M | 47.0M | 55.7M | 62.7M |
| Operating expense total | 93.1M | 149.2M | 203.4M | 224.0M | 223.9M |
| EBIT | (16.5M) | (34.8M) | (51.4M) | (55.7M) | (54.2M) |
| EBIT margin, % | -24.6% | -27.5% | -26.6% | -25.5% | |
| Investment income | 18.0K | 910.0K | 6.7M | 4.9M | 2.8M |
| Interest expense | 5.2M | 5.3M | |||
| Net Income | (20.6M) | (42.8M) | (49.5M) | (55.7M) | (59.0M) |
| EPS | (0.8) | (0.8) | (0.9) | (0.9) |